BeOne Medicines Ltd. (ONC)
354.47
+4.34
(+1.24%)
USD |
NASDAQ |
Oct 09, 16:00
354.12
-0.35
(-0.10%)
After-Hours: 20:00
BeOne Medicines Profit Margin (Quarterly) : 13.90% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 13.90% |
| March 31, 2026 | 15.02% |
| December 31, 2025 | 4.44% |
| September 30, 2025 | 8.84% |
| June 30, 2025 | 7.17% |
| March 31, 2025 | 0.11% |
| December 31, 2024 | -13.47% |
| September 30, 2024 | -12.12% |
| June 30, 2024 | -12.96% |
| March 31, 2024 | -33.41% |
| December 31, 2023 | -57.94% |
| September 30, 2023 | 27.57% |
| June 30, 2023 | -64.03% |
| March 31, 2023 | -77.81% |
| December 31, 2022 | -117.2% |
| September 30, 2022 | -143.8% |
| June 30, 2022 | -165.6% |
| March 31, 2022 | -141.9% |
| December 31, 2021 | -276.0% |
| September 30, 2021 | -212.2% |
| June 30, 2021 | -320.2% |
| March 31, 2021 | 10.98% |
| Date | Value |
|---|---|
| December 31, 2020 | -472.2% |
| September 30, 2020 | -468.4% |
| June 30, 2020 | -512.4% |
| March 31, 2020 | -701.0% |
| December 31, 2019 | -681.8% |
| September 30, 2019 | -615.6% |
| June 30, 2019 | -35.32% |
| March 31, 2019 | -215.9% |
| December 31, 2018 | -454.6% |
| September 30, 2018 | -266.6% |
| June 30, 2018 | -298.7% |
| March 31, 2018 | -323.0% |
| December 31, 2017 | -546.3% |
| September 30, 2017 | 53.26% |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | -6.14K% |
| March 31, 2016 | -3.25K% |
| December 31, 2015 | -582.6% |
| September 30, 2015 | -721.2% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| AC Immune SA | 12.40% |
| CRISPR Therapeutics AG | -895.3% |
| Idorsia Ltd. | -202.5% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 14.81% |
| Return on Assets | 8.24% |
| Return on Invested Capital | 10.52% |
| Gross Profit Margin (Quarterly) | 87.80% |
| Operating Margin (Quarterly) | 19.06% |
| Return on Net Operating Assets | 18.95% |